OPRX

OptimizeRx: Expects FY Results Will Come in at Higher End of Its Guidance Range for Revenue & Adjusted Ebitda

时间:2024-12-23 21:45:00 市场: 美股 综合

关联: OPRX

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

时间:2024-12-23 21:45:00 市场: 美股 综合

关联: OPRX

OptimizeRx Corp: Reaffirms Its Financial Guidance for Full Year 2024

时间:2024-12-23 21:45:00 市场: 美股 综合

关联: OPRX